Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Edoxaban: How Does the Newest Agent Fit into the DOAC Landscape?
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Edoxaban: How Does the Newest Agent Fit into the DOAC Landscape?'. Together they form a unique fingerprint.
edoxaban
Medicine & Life Sciences
100%
Anticoagulants
Medicine & Life Sciences
60%
Venous Thromboembolism
Medicine & Life Sciences
28%
Factor Xa Inhibitors
Medicine & Life Sciences
18%
Antidotes
Medicine & Life Sciences
16%
Warfarin
Medicine & Life Sciences
13%
United States Food and Drug Administration
Medicine & Life Sciences
13%
Atrial Fibrillation
Medicine & Life Sciences
11%
Cite this